CYAD - Celyad Oncology's (CYAD) CEO Filippo Petti on First Half 2020 Results - Earnings Call Transcript
Celyad Oncology SA (CYAD)
First Half 2020 Earnings Conference Call
August 07, 2020 8:00 AM ET
Company Participants
Filippo Petti – Chief Executive Officer
David Gilham – Chief Scientific Officer
Conference Call Participants
Raju Prasad – William Blair
Jim Birchenough – Wells Fargo
Ed White – H.C. Wainwright
Sandra Cauwenberghs – KBC Securities
Olga Smolentseva – Bryan, Garnier & Company
Presentation
Operator
Greetings. Welcome to the Celyad Oncology First Half 2020 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] Please